欧康维视提示

本内容仅供医学专业人士使用。如果您是医学专业人士,请点击确认,进入页面;否则请点击退出,返回上一页。
Home/Investors/Public Disclosure/Announcements and Circulars
Announcements and Circulars
2024-12-04
Next Day Disclosure Return
2024-12-04
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 November 2024
2024-12-03
VOLUNTARY ANNOUNCEMENT PATIENT ENROLLMENT COMPLETED IN THE SECOND PHASE III CLINICAL TRIAL OF OT-301 IN CHINA
2024-12-02
Next Day Disclosure Return
2024-11-29
Next Day Disclosure Return
2024-11-28
Next Day Disclosure Return
2024-11-27
Next Day Disclosure Return
2024-11-26
Next Day Disclosure Return
2024-11-25
Next Day Disclosure Return
2024-11-22
Next Day Disclosure Return
2024-11-21
Next Day Disclosure Return
2024-11-20
Next Day Disclosure Return
2024-11-19
Next Day Disclosure Return
2024-11-18
Next Day Disclosure Return
2024-11-15
Next Day Disclosure Return
2024-11-14
Next Day Disclosure Return
2024-11-13
Next Day Disclosure Return
2024-11-12
Next Day Disclosure Return
2024-11-11
Next Day Disclosure Return
2024-11-08
Next Day Disclosure Return
2024-11-07
Next Day Disclosure Return
2024-11-06
Next Day Disclosure Return
2024-11-06
Next Day Disclosure Return
2024-11-04
Next Day Disclosure Return
2024-11-01
Next Day Disclosure Return
2024-11-01
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2024
2024-10-31
Next Day Disclosure Return
2024-10-30
Next Day Disclosure Return
2024-10-29
Next Day Disclosure Return
2024-10-28
Next Day Disclosure Return
2024-10-25
Next Day Disclosure Return
2024-10-21
RESIGNATION OF A NON-EXECUTIVE DIRECTOR
2024-10-21
List of Directors and their Role and Function
2024-10-17
Next Day Disclosure Return
2024-10-16
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON OCTOBER 16, 2024
2024-10-16
Next Day Disclosure Return
2024-10-15
Next Day Disclosure Return
2024-10-14
Next Day Disclosure Return
2024-10-10
Next Day Disclosure Return
2024-10-09
Next Day Disclosure Return
2024-10-08
Next Day Disclosure Return
2024-10-07
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2024
2024-09-29
(1) VERY SUBSTANTIAL ACQUISITION IN RELATION TO ACQUISITION OF TRANSFERRED PRODUCTS, IN-LICENSING OF LICENSED PRODUCTS AND PROPOSED ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE&#x3b; (2) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE PURCHASE ARRANGEMENTS, ROYALTY PAYMENTS AND MILESTONE PAYMENTS&#x3b; AND (3) NOTICE OF EXTRAORDINARY GENERAL MEETING
2024-09-29
Documents on Display Multi-Files
2024-09-29
NOTICE OF EXTRAORDINARY GENERAL MEETING
2024-09-29
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON WEDNESDAY, OCTOBER 16, 2024
2024-09-27
CLOSURE OF REGISTER OF MEMBERS FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON OCTOBER 16, 2024
2024-09-26
Next Day Disclosure Return
2024-09-25
Next Day Disclosure Return
2024-09-24
Next Day Disclosure Return
2024-09-23
VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION OF OT-502 ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
2024-09-19
VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION OF OT-1001 APPROVED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
2024-09-19
Next Day Disclosure Return
2024-09-17
FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO (1) VERY SUBSTANTIAL ACQUISITION IN RELATION TO ACQUISITION OF TRANSFERRED PRODUCTS, IN-LICENSING OF LICENSED PRODUCTS AND PROPOSED ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE AND (2) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE PURCHASE ARRANGEMENT, ROYALTY PAYMENTS AND MILESTONE PAYMENTS
2024-09-10
2024 Interim Report
2024-09-03
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 August 2024
2024-09-02
DELAY IN DESPATCH OF CIRCULAR IN RELATION TO (1) VERY SUBSTANTIAL ACQUISITION IN RELATION TO ACQUISITION OF TRANSFERRED PRODUCTS, IN-LICENSING OF LICENSED PRODUCTS AND PROPOSED ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE AND (2) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE PURCHASE ARRANGEMENT, ROYALTY PAYMENTS AND MILESTONE PAYMENTS
2024-08-30
Next Day Disclosure Return
2024-08-29
Next Day Disclosure Return
2024-08-29
Next Day Disclosure Return (Resubmission)
2024-08-28
Next Day Disclosure Return
2024-08-27
Next Day Disclosure Return
2024-08-26
Next Day Disclosure Return
2024-08-23
Next Day Disclosure Return
2024-08-22
VOLUNTARY ANNOUNCEMENT PROPOSED ON-MARKET SHARE REPURCHASE
2024-08-22
Next Day Disclosure Return
2024-08-21
Next Day Disclosure Return
2024-08-20
Next Day Disclosure Return
2024-08-19
Next Day Disclosure Return
2024-08-16
Next Day Disclosure Return
2024-08-15
Next Day Disclosure Return
2024-08-12
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024
2024-08-12
(1) VERY SUBSTANTIAL ACQUISITION IN RELATION TO ACQUISITION OF TRANSFERRED PRODUCTS, IN-LICENSING OF LICENSED PRODUCTS AND PROPOSED ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE AND (2) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE PURCHASE ARRANGEMENT, ROYALTY PAYMENTS AND MILESTONE PAYMENTS
2024-08-05
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2024
2024-07-30
NOTICE OF BOARD MEETING
2024-07-16
VOLUNTARY ANNOUNCEMENT BIOLOGIC LICENSE APPLICATION FOR OT-702 ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
2024-07-04
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2024
2024-06-20
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 20, 2024
2024-06-06
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2024
2024-06-03
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2024
2024-05-23
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 20, 2024
2024-05-23
NOTICE OF ANNUAL GENERAL MEETING
2024-05-23
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; PROPOSED RE-ELECTION OF RETIRING DIRECTORS; PROPOSED RE-APPOINTMENT OF AUDITOR; PROPOSED AMENDMENTS TO THE 2021 SHARE OPTION SCHEME; PROPOSED AMENDMENTS TO THE 2021 SHARE AWARD SCHEME; AND NOTICE OF ANNUAL GENERAL MEETING
2024-05-23
Documents on Display Multi-Files
2024-05-23
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; PROPOSED RE-ELECTION OF RETIRING DIRECTORS&#x3b; PROPOSED RE-APPOINTMENT OF AUDITOR&#x3b; PROPOSED AMENDMENTS TO THE 2021 SHARE OPTION SCHEME&#x3b; PROPOSED AMENDMENTS TO THE 2021 SHARE AWARD SCHEME&#x3b; AND NOTICE OF ANNUAL GENERAL MEETING
2024-05-21
Next Day Disclosure Return
2024-05-06
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2024
2024-04-25
2023 Annual Report
2024-04-25
2023 Environmental, Social and Governance Report
2024-04-15
VOLUNTARY ANNOUNCEMENT PRIMARY ENDPOINTS ACHIEVED IN THE PHASE III CLINICAL TRIAL OF OT-502 IN CHINA
2024-04-08
VOLUNTARY ANNOUNCEMENT COMPLETION OF THE PHASE III CLINICAL TRIAL OF OT-702 IN CHINA
2024-04-03
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2024
2024-03-22
(I) PROPOSED AMENDMENTS TO THE 2021 SHARE OPTION SCHEME; AND (II) PROPOSED AMENDMENTS TO THE 2021 SHARE AWARD SCHEME
2024-03-22
(I) PROPOSED AMENDMENTS TO THE 2021 SHARE OPTION SCHEME&#x3b; AND (II) PROPOSED AMENDMENTS TO THE 2021 SHARE AWARD SCHEME
2024-03-21
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
2024-03-14
VOLUNTARY ANNOUNCEMENT PRIMARY ENDPOINTS ACHIEVED IN THE PHASE II CLINICAL TRIAL OF OT-202
2024-03-07
DATE OF BOARD MEETING
2024-03-01
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 29 February 2024
2024-02-09
Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
2024-02-09
Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
2024-02-01
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2024
2024-01-19
Next Day Disclosure Return
2024-01-18
Next Day Disclosure Return
2024-01-17
Next Day Disclosure Return
2024-01-17
DISCLOSEABLE TRANSACTION DISPOSAL OF SHARES IN EYEPOINT PHARMACEUTICALS, INC.
2024-01-16
Next Day Disclosure Return
2024-01-15
Next Day Disclosure Return
2024-01-12
Next Day Disclosure Return
2024-01-11
Next Day Disclosure Return (Resubmission)
2024-01-11
Next Day Disclosure Return (Resubmission)
2024-01-10
Next Day Disclosure Return
2024-01-09
Next Day Disclosure Return
2024-01-08
Next Day Disclosure Return
2024-01-05
Next Day Disclosure Return
2024-01-04
Next Day Disclosure Return
2024-01-03
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 December 2023
2024-01-03
Next Day Disclosure Return
2024-01-02
Next Day Disclosure Return
Follow us